Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated Jun 22, 2024, titled "Sun Pharma s GL0034 (Utreglutide) Demonstrates Significant Weight Loss, Gluco-metabolic and Lipid Lowering Efficacy in Individuals with Obesity in Oral Presentation at the American Diabetes Association 84th Scientific Sessions".